---
title: "DSS Secures $2.45 Million 3% Five-Year Convertible Note With Warrants From Alset International"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281246291.md"
description: "DSS has secured a $2.45 million convertible promissory note with Alset International, featuring a 3% interest rate and a five-year maturity. The note is convertible at $0.74 per share, while the accompanying warrants cover 16,554,055 shares at an exercise price of $0.93, expiring in five years. The agreement aims to enhance liquidity and fund operations, pending customary conditions including stockholder approval."
datetime: "2026-03-31T21:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281246291.md)
  - [en](https://longbridge.com/en/news/281246291.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281246291.md)
---

# DSS Secures $2.45 Million 3% Five-Year Convertible Note With Warrants From Alset International

DSS entered into a securities purchase agreement with Alset International for a $2.45 million convertible promissory note and warrants. The 3% note is convertible at $0.74 per share before its five-year maturity; the warrants cover 16,554,055 shares at a $0.93 exercise price and expire in five years. Closing is subject to customary conditions, including stockholder approval, and is intended to strengthen liquidity.

**Agreement details:**

-   **Agreement type**: $2.45 million 3% five-year convertible note with warrants
-   **Counterparty**: Alset International
-   **Signed / Effective**: Mar 26 2026 / same
-   **Duration / Termination**: 5 years
-   **Reason**: Enhance liquidity and fund operations

Original SEC Filing: DSS, INC. \[ DSS \] - 8-K - Mar. 31, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [AEI.US](https://longbridge.com/en/quote/AEI.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [DSS.US](https://longbridge.com/en/quote/DSS.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)

## Related News & Research

- [DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing | DSS Stock News](https://longbridge.com/en/news/285775825.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [US FDA approves BeOne's drug for a type of blood cancer](https://longbridge.com/en/news/286298271.md)
- [vTv Therapeutics posts Q1 profit on license payment](https://longbridge.com/en/news/286309828.md)
- [GRI Bio Highlights Promising Phase 2a IPF Data, Outlook](https://longbridge.com/en/news/286422240.md)